How might medicinal regulators evolve in their expectations for ENDS
13:40 - 13:55
Industry, Policy and Regulation
While ENDS products appear to have had a significant impact on smoking within a tobacco regulatory framework, there has been zero progress in expanding market-available choice of such products within a medicinal framework. There is broad consensus at least on the part of regulators and tobacco control that a medicinal ENDS product would have a positive public health impact. But is the medicinal pathway truly viable? If not, why not?
- Considerations re Safety, Efficacy, and Quality
- MHRA and FDA comparisons
- NRT & ENDS Product Characteristics
« Back to previous page